Oncotelic Therapeutics Inc. (OTCQB: OTLC) Anticipates Major Fair-Value Uptick Following New Independent JV Valuation

(OTC US:OTLC),(Other OTC:OTLC), NEW YORK, Nov. 25, 2025 (GLOBE NEWSWIRE) — via BioMedWire — Oncotelic Therapeutics Inc. (OTCQB: OTLC) today announces its placement in an editorial published by BioMedWire (BMW), one of 75+ brands within the Dynamic Brand Portfolio@IBN (InvestorBrandNetwork), a specialized communications platform with a focus on financial news and content distribution for private […]

Nightfood Holdings Inc. (NGTF) Posts Strong Earnings, Progresses Toward Uplisting

(Other OTC:NGTF),(OTC US:NGTF), NEW YORK, Nov. 25, 2025 (GLOBE NEWSWIRE) — via AINewsWire — Nightfood Holdings inc. (NGTF) today announces its placement in an editorial published by AINewsWire (“AINW”), one of 75+ brands within the Dynamic Brand Portfolio@IBN (InvestorBrandNetwork), a specialized communications platform with a focus on financial news and content distribution for private and

Palm Beach County Hosts Online Auction for 2 TigerShark UAS Drones on GovDeals

WEST PALM BEACH, Fla., Nov. 25, 2025 (GLOBE NEWSWIRE) — The Palm Beach County, FL Sheriff's Office is currently hosting an online auction for two TigerShark UAS Drones on GovDeals, the leading online marketplace for government agencies to sell equipment, vehicles and other surplus assets. The auction is live now and closes December 4. It

BitMEX Launches the ‘BitMEX Legends’ Campaign With a 5 BTC Prize Pool to Celebrate 11-Year Anniversary

VICTORIA, Seychelles, Nov. 25, 2025 (GLOBE NEWSWIRE) — BitMEX, one of the safest crypto exchanges, recently announced the launch of the 'BitMEX Legends,' a global campaign featuring a 5 BTC and 100,000 USDT prize pool to celebrate its 11-year anniversary. The campaign, which began on 24 November, is available to new, existing, and returning traders

PolyPid to Participate in ROTH Capital Partners Virtual KOL Event on December 10, 2025

PolyPid to Participate in ROTH Capital Partners Virtual KOL Event on December 10, 2025 Internationally recognized colorectal surgeon Steven D. Wexner, MD, FACS, FRCS, to discuss the clinical and economic burden of surgical site infections and the therapeutic potential of D-PLEXâ‚₀₀ GlobeNewswire November 25, 2025 PETACH TIKVA, Israel, Nov. 25, 2025 (GLOBE NEWSWIRE) — PolyPid

Fairchild Gold Joins Critical Minerals Forum

Fairchild Gold Joins Critical Minerals Forum Membership Provides Access to Government Stakeholders, Industry Leaders, and Capital Markets Through DARPA-Sponsored Initiative GlobeNewswire November 25, 2025 VANCOUVER, B.C., Nov. 25, 2025 (GLOBE NEWSWIRE) — via IBN — Fairchild Gold Corp. ('Fairchild' or the 'Company') (TSXV:FAIR)(OTCID:FCHDF)(Frankfurt:Y4Y), a mineral exploration and development company focused on copper and gold in

Barnes & Noble Education Announces Preliminary Full-Year Fiscal 2025 and Year-to-Date Fiscal 2026 Unaudited Financial Results

Barnes & Noble Education Announces Preliminary Full-Year Fiscal 2025 and Year-to-Date Fiscal 2026 Unaudited Financial Results GlobeNewswire November 25, 2025 Company Announces the Conclusion and Findings of Internal Investigation Releases Preliminary FY2025 and First Half 2026 Results First Day Complete Enrollment for Fall 2025 Estimated to Grow 24%* Board of Directors Pleased with Revenue Growth

GCL Announces Fiscal Year 2026 Revenue and Gross Profit Expectations

GCL Announces Fiscal Year 2026 Revenue and Gross Profit Expectations GlobeNewswire November 25, 2025 SINGAPORE, Nov. 25, 2025 (GLOBE NEWSWIRE) — GCL Global Holdings Ltd (Nasdaq: GCL) (“GCL” or the “Company”), a leading provider of games and entertainment, today provided an update on management's expectations for financial results for the fiscal year 2026, ending March

MACOM Promotes Robert Dennehy to Chief Operating Officer

MACOM Promotes Robert Dennehy to Chief Operating Officer GlobeNewswire November 25, 2025 LOWELL, Mass., Nov. 25, 2025 (GLOBE NEWSWIRE) — MACOM Technology Solutions Holdings, Inc. (“MACOM”) (Nasdaq: MTSI), a leading supplier of semiconductor products, today announced the promotion of Robert Dennehy to Chief Operating Officer (“COO”). In this role, Mr. Dennehy will continue to oversee

Tiziana Life Sciences Nasal Foralumab Phase 2 Clinical Trial Accepted into Healey ALS MyMatch Program

Tiziana Life Sciences Nasal Foralumab Phase 2 Clinical Trial Accepted into Healey ALS MyMatch Program GlobeNewswire November 25, 2025 BOSTON, Nov. 25, 2025 (GLOBE NEWSWIRE) — Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies, today announced that its Phase 2 clinical trial evaluating intranasal foralumab in

Scroll to Top